Skip to main content

Table 1 Patient characteristics (n = 226)

From: Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Age at HTx, mean ± SD, years  
 Recipient (R) 45 ± 13
 Donor (D) 33 ± 12
Male gender, n (%)  
 Recipient 176 (78)
 Donor 159 (70)
Body mass index at HTx, mean ± SD kg/m2 23.8 ± 3.9
Cold ischemic time, mean ± SD minutes CMV serology, n (%) 168 ± 49
 D+ /R− 46 (20)
 D+ /R+ 101 (45)
 D− /R+ 64 (28)
 D− /R− 15 (7)
Induction therapy, n (%)  
 CsA 48 (21)
 ATG 165 (73)
 Daclizumab 4 (2)
 Prednisone 9 (4)
CAD, n (%) 73 (32)
Hypertension, n (%) 30 (13)
Diabetes Mellitus, n (%) 23 (10)
Previous smoking, n (%) 127 (56)
TRS at 1 year, mean ± SD 0.49 ± 0.30
TRS ≥ 2R at 1 year, mean ± SD 0.22 ± 0.20